AzTrials
AzTrials

AphasiaMETALEXNCT06930131

Effect of Anomia Rehabilitation Combined With Metacognitive Training in Patients With Chronic Vascular Aphasia

A study testing Semantic rehabilitation in people with Aphasia and Stroke, run by University Hospital, Toulouse at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The postulate of this study is that rehabilitation combining linguistic and metacognitive training will result in a significant improvement in language performance correlated with changes in functional cerebral connectivity networks. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Aphasia, Stroke
What is being tested?
Semantic rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteFrance
Study dates
21 Feb 2025to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • First cerebral infarction
  • Chronic phase (> 3 months)
  • Patient affiliated to a health insurance scheme
  • Usual french language
  • Severity score measures using the Boston Diagnostic Aphasia Examination battery scale corresponding to the mild or moderate level (score greater than or equal to 2)

Who cannot join

  • Contraindication to undergoing brain MRI
  • Cognitive impairment pre-existing stroke (CQI code > 3.4) (Law et al., 1995)
  • Chronic alcohol or drug abuse
  • Unstabilised psychiatric illness
  • Uncorrected sensory deficits
  • Diagnosed as having a progressive general pathology

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • University Hospital of Toulouse

    Toulouse

    Lola Danet, phD, danet.l@chu-toulouse.fr

    Recruiting

Other trials in France

About this study

The postulate of this study is that rehabilitation combining linguistic and metacognitive training will result in a significant improvement in language performance correlated with changes in functional cerebral connectivity networks. In addition, it could potentiate the generalisation of effects to verbal and non-verbal communication skills, having a direct impact on patients' quality of life. This research is a prospective, randomized controlled, open-label, single-centre study. It is part of the management of patients with aphasia who have suffered a cerebral infarction and aims to evaluate the effect of combined language semantics/metacognition rehabilitation.

Read the detailed description

Vascular aphasia occurs after 20 to 25% of strokes and leads to anomia or word-finding difficulties in many patients. Speech therapy, which is the standard treatment, notably employs Semantic Feature Analysis (SFA). SFA aims to teach patients a strategy that helps activate semantic links strongly associated with the target word, thereby facilitating word retrieval.

Moreover, a growing number of studies suggest combining metacognitive strategy training with language rehabilitation in brain-injured patients, particularly in reading comprehension, communication skills, and anomia, could improve cognitive and language recovery outcomes. In rehabilitation, metacognitive strategy training can be used to enhance and/or compensate for cognitive function deficits. Patients are repeatedly exposed to discrepancies between the patients performance evaluations and expectations. Findings indicate improvements in trained tasks and transfer effects to similar tasks.

While studies have examined the effects of linguistic training on one hand and the impact of metacognitive abilities on the other, to the investigators knowledge, no study has assessed the effect of a combined linguistic and metacognitive training approach in post-stroke aphasic patients on behavioral and imaging variables. This study postulates that rehabilitation combining linguistic and metacognitive training will lead to a significant improvement in language performance, correlated with changes in functional brain connectivity networks. Furthermore, it may enhance the generalization of effects to both verbal and non-verbal communication skills, directly impacting patients' quality of life.

Conditions
Aphasia, Stroke
Being tested
Semantic rehabilitation
Keywords
Aphasia, Stroke, Chronic, Cognitive rehabilitation, SCED
Medical subject headings
Aphasia, Stroke, Bronchiolitis Obliterans Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Semantic rehabilitationBehavioural

    Semantic rehabilitation, consisting of validated lexico-phonological training exercises

Study groups in NCT06930131
Study groupRoleWhat they receive
6 weeks phase A (Baseline)OtherNot described
Receives: Behavioral: Semantic rehabilitation
7 weeks phase A (Baseline)OtherNot described
Receives: Behavioral: Semantic rehabilitation
8 weeks phase A (Baseline)OtherNot described
Receives: Behavioral: Semantic rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Performance at the "TD-264" untrained naming items task

    The "TD-264 untrained naming items task" is a naming task of 264 images. Words corresponding to the images correctly named are "set success" and words wrongly named are "set treatment".

    The score at the task is composite :

    • reaction time allowing the speed of evocation to be measured will be measured with the Audacity software (https://audacity.fr/).
    • accuracy will be rated
    1. quantitatively : number of "set success"
    2. qualitatively : description of naming behaviors

    Scores are all from 0 to 264. 0 being the worst performance possible and 264 being the best performance possible.

    Measured: Baseline, Up to 8 weeks, Up to 13 weeks

Secondary outcomes (1)
  1. Reorganization of patients' functional connectivity maps compared to healthy volunteers

    Reorganization of the functional connectivity of patients measured by the difference between the activation maps at the end of phase A and at the end of phase B, thanks to the acquisition of resting functional MRI sequences on the MRI dedicated to research (acquisition of resting-state MRI sequences)

    Measured: Up to 8 weeks ; Up to 13 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2025
  2. Study start21 Feb 2025
  3. Primary completionDec 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
18 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06930131
Sponsor's protocol ID
RC31/22/0503
Other IDs
2024-A01842-45
Acronym
METALEX
Status last verified
Nov 2026
First submitted
19 Feb 2025
Last updated
5 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Semantic rehabilitation in people with Aphasia and Stroke, run by University Hospital, Toulouse at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lola DANET (05 61 77 76 86, danet.l@chu-toulouse.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Performance at the "TD-264" untrained naming items task (time frame: Baseline, Up to 8 weeks, Up to 13 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2026; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in